Skip to Main Content
  • About Us
  • People
  • Capabilities
  • News & Insights
  • Events
  1. Insights
  2. Experience

Strategic Investment and Merger for CyVek, Inc.

Lawyers

J. Dormer Stephen bio photo
J. Dormer Stephen

Partner

203.836.2803

dstephen@goodwin.com
Donna Brooks bio photo
Donna L. Brooks

Partner

860.251.5917

dbrooks@goodwin.com
Miriam Lewis Headshot
Miriam Lewis

Partner

860.251.5007

mlewis@goodwin.com
Matthew Monteith Bio Photo
Matthew J. Monteith

Partner

860.251.5784

mmonteith@goodwin.com
  • -

Shipman & Goodwin, which has been engaged by CyVek since its formation in 2008, is proud to have served as CyVek’s trusted legal counsel in the strategic transaction with Techne Corporation, the most important transaction in CyVek’s corporate history. The firm’s legal team included Dormer Stephen, Donna Brooks, Matt Monteith and Miriam Lewis.

CyVek’s CyPlexTM technology integrates an innovatively designed microfluidic cartridge with a state-of-the-art analyzer to deliver the most advanced and efficient bench top immunoassay system. CyPlex’sTM ability to provide "sample to answer" test results precisely and quickly in a sealed disposable device makes it a very attractive platform for clinical applications. The CyPlexTM technology has demonstrated broad applicability across numerous sectors, including routine life sciences research applications.

Related Practices

  • Business and Corporate
  • Mergers, Acquisitions and Joint Ventures
  • Commercial Finance

Keep in Touch

Stay current with our latest insights

Manage Subscriptions
  • Lawyers
  • Capabilities
  • Events
  • Diversity, Equity and Inclusion
  • Pro Bono and Community
  • Blogs and Resource Centers
  • Insights
  • Podcasts
  • Dobbs Decision Resource Center
  • About Us
  • Careers
  • Contact Us
  • Disclaimer
  • Privacy Policy
  • Terms of Use
  • Accessibility Statement

© Shipman & Goodwin LLP 2025. All Rights Reserved